Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica M Logan

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Molecular Diagnosis & Therapy|December 8, 2022
Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable MarkersGiang T Lam, Sarita Prabhakaran, Alexandra Sorvina, et al.
Cancer Letters|January 4, 2025
Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancerMadison T Hindes, Anthony M McElligott, Oliver G Best, et al.
Cancer Letters|January 30, 2024
Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome systemJingying Tang, Giang T Lam, Robert D Brooks, et al.
Cancers|September 28, 2023
Insights into Melanoma Clinical Practice: A Perspective for Future ResearchGiang T Lam, Carmela Martini, Tiffany Brooks, et al.
Pathology|July 8, 2023
Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spreadAlexandra Sorvina, Carmela Martini, Sarita Prabhakaran, et al.
Cancer Medicine|October 30, 2025
Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast CancerNatansh D Modi, Ahmad Y Abuhelwa, Nicole M Kuderer, et al.
Scientific Data|August 8, 2024
Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkersJessica M Logan, Carmela Martini, Alexandra Sorvina, et al.
Pathology, Research and Practice|December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancerMark Bates, Dorinda Mullen, Eimear Lee, et al.
British Journal of Cancer|August 31, 2024
Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progressionBukuru D Nturubika, Carlos M Guardia, David C Gershlick, et al.
Neoplasia (New York, N.Y.)|August 10, 2023
Altered endosomal-lysosomal biogenesis in melanomaGiang T Lam, Alexandra Sorvina, Carmela Martini, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Molecular Diagnosis & Therapy|December 8, 2022
Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable MarkersGiang T Lam, Sarita Prabhakaran, Alexandra Sorvina, et al.
Cancer Letters|January 4, 2025
Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancerMadison T Hindes, Anthony M McElligott, Oliver G Best, et al.
Cancer Letters|January 30, 2024
Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome systemJingying Tang, Giang T Lam, Robert D Brooks, et al.
Cancers|September 28, 2023
Insights into Melanoma Clinical Practice: A Perspective for Future ResearchGiang T Lam, Carmela Martini, Tiffany Brooks, et al.
Pathology|July 8, 2023
Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spreadAlexandra Sorvina, Carmela Martini, Sarita Prabhakaran, et al.
Cancer Medicine|October 30, 2025
Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast CancerNatansh D Modi, Ahmad Y Abuhelwa, Nicole M Kuderer, et al.
Scientific Data|August 8, 2024
Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkersJessica M Logan, Carmela Martini, Alexandra Sorvina, et al.
Pathology, Research and Practice|December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancerMark Bates, Dorinda Mullen, Eimear Lee, et al.
British Journal of Cancer|August 31, 2024
Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progressionBukuru D Nturubika, Carlos M Guardia, David C Gershlick, et al.
Neoplasia (New York, N.Y.)|August 10, 2023
Altered endosomal-lysosomal biogenesis in melanomaGiang T Lam, Alexandra Sorvina, Carmela Martini, et al.
Pageof 5